Table 1 The international criteria for Behcet’s disease
From: An immune-related adverse event of Behcet’s-like syndrome following pembrolizumab treatment
Symptom | Score* |
|---|---|
Ocular lesions | Two points |
Genital aphthosis | Two points |
Oral aphthosis | Two points |
Skin lesions | One point |
Neurological manifestations | One point |
Vascular lesions | One point |
Pathergy | One point |